Does UPADACITINIB Cause Therapy cessation? 262 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 262 reports of Therapy cessation have been filed in association with UPADACITINIB (Rinvoq). This represents 0.4% of all adverse event reports for UPADACITINIB.
262
Reports of Therapy cessation with UPADACITINIB
0.4%
of all UPADACITINIB reports
1
Deaths
48
Hospitalizations
How Dangerous Is Therapy cessation From UPADACITINIB?
Of the 262 reports, 1 (0.4%) resulted in death, 48 (18.3%) required hospitalization, and 6 (2.3%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 262 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which UPADACITINIB Alternatives Have Lower Therapy cessation Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL